Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.57 USD | +1.29% | +13.54% | -22.70% |
04-15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
03-25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 23.82 | 26.08 | 32.66 |
Spread/Res. | -1.05% | -9.62% | -27.83% |
Spread/Supp. | +17.73% | +17.73% | +13.54% |
Support | 20.02 | 20.02 | 20.76 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.